(Q51346354)

4 April 2018

title

Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study. (English)

1 reference

4 April 2018

Hans-Peter Brunner-La Rocca

main subject

heart failure

0 references

author

8

object named as

Hans-Peter Brunner-La Rocca

1 reference

4 April 2018

Peter Rickenbacher

1

1 reference

4 April 2018

Matthias Pfisterer

2

1 reference

4 April 2018

Thilo Burkard

3

1 reference

4 April 2018

Wolfgang Kiowski

4

1 reference

4 April 2018

Ferenc Follath

5

1 reference

4 April 2018

Dieter Burckhardt

6

1 reference

4 April 2018

Ruth Schindler

7

1 reference

4 April 2018

TIME-CHF Investigators

9

1 reference

4 April 2018

publication date

6 July 2012

1 reference

4 April 2018

European Journal of Heart Failure

published in

1 reference

4 April 2018

volume

14

1 reference

4 April 2018

issue

11

1 reference

4 April 2018

page(s)

1218-1229

1 reference

4 April 2018

Epidemiology of diastolic heart failure

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Epidemiology and clinical course of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Frequent non-cardiac comorbidities in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Recognising the limits of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Hospitalizations after heart failure diagnosis a community perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Mode of death in chronic heart failure. A request and proposition for more accurate classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Outcome of heart failure with preserved ejection fraction in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Predictors of mortality and morbidity in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Competing risks of heart failure with preserved ejection fraction in diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Anemia and mortality in heart failure patients a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Death in heart failure: a community perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) progr

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Predictors of early readmission or death in elderly patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Trends in Heart Failure Incidence and Survival in a Community-Based Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS113

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFS113

1 reference

4 April 2018

1 reference

4 April 2018